SCHEMBL4482450

SCHEMBL4482450

CCCCOC1(C)N(C)C(=O)OC1(C)Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.45
GAA P10253 1/20 0.45
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
ELANE P08246 4/20 0.38
CTSG P08311 1/20 0.38
PRTN3 P24158 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
RECQL P46063 1/20 0.37
MMP2 P08253 2/20 0.36
MMP9 P14780 2/20 0.36
MMP8 P22894 2/20 0.36
MMP13 P45452 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4482455 0.76 ELANE (0.42) L3MBTL1CYP2C9CYP2C19NPSR1ELANE
SCHEMBL4455507 0.69 GAA (0.50) L3MBTL1GAAELANECTSGPRTN3
SCHEMBL4322743 0.68 CYP2C9 (0.38) GAACYP2C9CYP2C19NPSR1ELANE
SCHEMBL28674345 0.64 LTA4H (0.38) L3MBTL1CYP2C9CYP2C19NPSR1ELANE
SCHEMBL28674344 0.63 MMP1 (0.38) L3MBTL1GAACYP2C9CYP2C19NPSR1
SCHEMBL6553757 0.61 MEN1 (0.43) L3MBTL1CYP2C9CYP2C19ELANETDP1
SCHEMBL8105297 0.58 TP53 (0.41) NPSR1ELANEMMP2MMP9MMP8
SCHEMBL1587776 0.58 ELANE (0.42) L3MBTL1GAANPSR1ELANECTSG
SCHEMBL28382522 0.58 CYP2C9 (0.50) L3MBTL1CYP2C9CYP2C19NPSR1TDP1
SCHEMBL16174713 0.57 ELANE (0.44) L3MBTL1GAACYP2C9CYP2C19ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137577-A1 HETEROCYCLIC COMPOUNDS PFIZER INC. 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137577-A1 HETEROCYCLIC COMPOUNDS CYP2D6, ABCG2, CYP2B6 L3MBTL1 4751/4885GAA 121/4885CYP2C9 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.